EssilorLuxottica S.A.
ESLOFOTCHealthcare● Active
$199.02
$-2.85(-1.41%)
Market Cap$92.4B
P/E Ratio—
52W High$376.38
52W Low$191.09
EssilorLuxottica S.A.（ESLOF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ESLOF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $2.31B | $2.49B | $2.29B | $2.28B | $1.61B |
| Depreciation & Amort. | $3.11B | $3.10B | $2.95B | $2.92B | $2.46B |
| Stock-Based Comp. | $0.00B | $0.16B | $0.20B | $0.19B | $0.16B |
| Change in Working Capital | ($0.47B) | ($0.70B) | ($0.43B) | ($0.41B) | $0.37B |
| Net Cash from Operations | $5.29B | $4.87B | $4.86B | $4.78B | $4.54B |
| Investing Activities | |||||
| Capital Expenditure | ($1.52B) | ($1.52B) | ($1.53B) | ($1.57B) | ($1.03B) |
| Purchases of Investments | ($0.14B) | $0.00B | $0.00B | ($0.18B) | ($0.10B) |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.18B | $0.10B |
| Net Cash from Investing | ($2.64B) | ($3.62B) | ($1.72B) | ($2.62B) | ($8.06B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.38B) | ($0.27B) | ($0.27B) | ($0.43B) | ($0.32B) |
| Dividends Paid | ($0.55B) | ($1.16B) | ($0.49B) | ($0.45B) | ($0.14B) |
| Debt Issued / Repaid | $0.99B | $1.08B | ($1.53B) | ($1.41B) | ($1.45B) |
| Net Cash from Financing | ($0.97B) | ($1.65B) | ($2.42B) | ($3.58B) | ($2.04B) |
| Free Cash Flow | |||||
| Free Cash Flow | $3.76B | $3.35B | $3.33B | $3.21B | $3.52B |
| FCF Margin %(computed) | 13.22% | 12.65% | 13.11% | 13.11% | 17.73% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · EUR · B
深入了解EssilorLuxottica S.A.
关于EssilorLuxottica S.A.（ESLOF）现金流量表
EssilorLuxottica S.A. 2025财年经营活动现金流$5.29B，自由现金流$3.76B（FCF利润率13.22%），资本支出($1.52B)。
常见问题
ESLOF · 4 问EssilorLuxottica S.A. 2025财年自由现金流$3.76B，同比up12.3%。
ESLOF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10